BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15109497)

  • 1. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block.
    Pashmforoush M; Lu JT; Chen H; Amand TS; Kondo R; Pradervand S; Evans SM; Clark B; Feramisco JR; Giles W; Ho SY; Benson DW; Silberbach M; Shou W; Chien KR
    Cell; 2004 Apr; 117(3):373-86. PubMed ID: 15109497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein.
    Kasahara H; Wakimoto H; Liu M; Maguire CT; Converso KL; Shioi T; Huang WY; Manning WJ; Paul D; Lawitts J; Berul CI; Izumo S
    J Clin Invest; 2001 Jul; 108(2):189-201. PubMed ID: 11457872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development.
    Moskowitz IP; Kim JB; Moore ML; Wolf CM; Peterson MA; Shendure J; Nobrega MA; Yokota Y; Berul C; Izumo S; Seidman JG; Seidman CE
    Cell; 2007 Jun; 129(7):1365-76. PubMed ID: 17604724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow progressive conduction and contraction defects in loss of Nkx2-5 mice after cardiomyocyte terminal differentiation.
    Takeda M; Briggs LE; Wakimoto H; Marks MH; Warren SA; Lu JT; Weinberg EO; Robertson KD; Chien KR; Kasahara H
    Lab Invest; 2009 Sep; 89(9):983-93. PubMed ID: 19546853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in cardiac conduction system lineages and malignant arrhythmias: developmental pathways and disease.
    St Amand TR; Lu JT; Chien KR
    Novartis Found Symp; 2003; 250():260-70; discussion 271-5, 276-9. PubMed ID: 12956335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome.
    Elliott DA; Kirk EP; Yeoh T; Chandar S; McKenzie F; Taylor P; Grossfeld P; Fatkin D; Jones O; Hayes P; Feneley M; Harvey RP
    J Am Coll Cardiol; 2003 Jun; 41(11):2072-6. PubMed ID: 12798584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.
    Terada R; Warren S; Lu JT; Chien KR; Wessels A; Kasahara H
    Cardiovasc Res; 2011 Jul; 91(2):289-99. PubMed ID: 21285290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy.
    Costa MW; Guo G; Wolstein O; Vale M; Castro ML; Wang L; Otway R; Riek P; Cochrane N; Furtado M; Semsarian C; Weintraub RG; Yeoh T; Hayward C; Keogh A; Macdonald P; Feneley M; Graham RM; Seidman JG; Seidman CE; Rosenthal N; Fatkin D; Harvey RP
    Circ Cardiovasc Genet; 2013 Jun; 6(3):238-47. PubMed ID: 23661673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital heart disease caused by mutations in the transcription factor NKX2-5.
    Schott JJ; Benson DW; Basson CT; Pease W; Silberbach GM; Moak JP; Maron BJ; Seidman CE; Seidman JG
    Science; 1998 Jul; 281(5373):108-11. PubMed ID: 9651244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy.
    Choquet C; Nguyen THM; Sicard P; Buttigieg E; Tran TT; Kober F; Varlet I; Sturny R; Costa MW; Harvey RP; Nguyen C; Rihet P; Richard S; Bernard M; Kelly RG; Lalevée N; Miquerol L
    PLoS Genet; 2018 Jul; 14(7):e1007502. PubMed ID: 29979676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies.
    Kasahara H; Benson DW
    Cardiovasc Res; 2004 Oct; 64(1):40-51. PubMed ID: 15364612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Model of Human Congenital Heart Disease: Progressive Atrioventricular Block Induced by a Heterozygous Nkx2-5 Homeodomain Missense Mutation.
    Chowdhury R; Ashraf H; Melanson M; Tanada Y; Nguyen M; Silberbach M; Wakimoto H; Benson DW; Anderson RH; Kasahara H
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1255-64. PubMed ID: 26226998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Msx2 does not affect cardiac conduction or rescue conduction defects associated with Nkx2-5 mutation.
    Jay PY; Maguire CT; Wakimoto H; Izumo S; Berul CI
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):82-5. PubMed ID: 15673394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects.
    Briggs LE; Takeda M; Cuadra AE; Wakimoto H; Marks MH; Walker AJ; Seki T; Oh SP; Lu JT; Sumners C; Raizada MK; Horikoshi N; Weinberg EO; Yasui K; Ikeda Y; Chien KR; Kasahara H
    Circ Res; 2008 Sep; 103(6):580-90. PubMed ID: 18689573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene.
    Gutierrez-Roelens I; Sluysmans T; Gewillig M; Devriendt K; Vikkula M
    Hum Mutat; 2002 Jul; 20(1):75-6. PubMed ID: 12112663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irx3 is required for postnatal maturation of the mouse ventricular conduction system.
    Kim KH; Rosen A; Hussein SM; Puviindran V; Korogyi AS; Chiarello C; Nagy A; Hui CC; Backx PH
    Sci Rep; 2016 Jan; 6():19197. PubMed ID: 26786475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tyrosine-rich domain within homeodomain transcription factor Nkx2-5 is an essential element in the early cardiac transcriptional regulatory machinery.
    Elliott DA; Solloway MJ; Wise N; Biben C; Costa MW; Furtado MB; Lange M; Dunwoodie S; Harvey RP
    Development; 2006 Apr; 133(7):1311-22. PubMed ID: 16510504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.
    Benson DW; Silberbach GM; Kavanaugh-McHugh A; Cottrill C; Zhang Y; Riggs S; Smalls O; Johnson MC; Watson MS; Seidman JG; Seidman CE; Plowden J; Kugler JD
    J Clin Invest; 1999 Dec; 104(11):1567-73. PubMed ID: 10587520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nkx2-5 suppresses the proliferation of atrial myocytes and conduction system.
    Nakashima Y; Yanez DA; Touma M; Nakano H; Jaroszewicz A; Jordan MC; Pellegrini M; Roos KP; Nakano A
    Circ Res; 2014 Mar; 114(7):1103-13. PubMed ID: 24563458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient.
    Hosoda T; Komuro I; Shiojima I; Hiroi Y; Harada M; Murakawa Y; Hirata Y; Yazaki Y
    Jpn Circ J; 1999 May; 63(5):425-6. PubMed ID: 10943630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.